Growth Metrics

AC Immune (ACIU) Revenue (2014 - 2026)

AC Immune (ACIU) reported Revenue of $1.4 million for Q1 2026, up 29.77% year-over-year from $1.1 million in Q1 2025, and up 237.9% on a QoQ basis from $422895.4 in Q4 2025.

AC Immune (ACIU) has 11 years of Revenue data on file, last reported at $1.4 million in Q1 2026.

  • Quarterly Revenue rose 29.77% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 85.87% YoY) and the FY2025 annual result came in at $4.3 million, down 86.18% from the prior year.
  • Revenue improved to $1.4 million in Q1 2026 per ACIU's latest filing, from $422895.4 in the prior quarter.
  • Across five years, Revenue topped out at $29.4 million in Q3 2024 and bottomed at $422895.4 in Q4 2025.
  • The 4-year median for Revenue is $1.3 million (2024), against an average of $4.6 million.
  • Peak annual rise in Revenue reached 107.65% in 2025, while the deepest fall reached 96.01% in 2025.
  • Tracing ACIU's Revenue over 4 years: stood at $4.0 million in 2022, then sank by 67.86% to $1.3 million in 2024, then sank by 67.42% to $422895.4 in 2025, then surged by 237.9% to $1.4 million in 2026.
  • Per Business Quant, the three latest ACIU Revenue figures stand at $1.4 million (Q1 2026), $422895.4 (Q4 2025), and $1.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 AC Immune 325.88 Mn 211.53 Mn - 1.43 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.43 Mn
Dec 31, 2025 422,895.39
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 29.41 Mn
Jun 30, 2024 759,680.13
Sep 30, 2022 4.04 Mn
Dec 31, 2020 1.04 Mn
Sep 30, 2020 1.22 Mn
Jun 30, 2020 1.12 Mn
Mar 31, 2020 12.70 Mn
Dec 31, 2019 868,929.92
Sep 30, 2019 2.23 Mn
Jun 30, 2019 1.51 Mn
Mar 31, 2019 75.35 Mn
Dec 31, 2018 1.13 Mn
Sep 30, 2018 2.34 Mn
Jun 30, 2018 2.06 Mn
Mar 31, 2018 1.54 Mn
Dec 31, 2017 14.19 Mn
Sep 30, 2017 1.04 Mn
Jun 30, 2017 811,998.96
Mar 31, 2017 2.00 Mn
Dec 31, 2016 1.51 Mn
Sep 30, 2016 1.33 Mn
Jun 30, 2016 14.43 Mn
Mar 31, 2016 490,368.94
Dec 31, 2015 670,993.25
Sep 30, 2015 25.30 Mn
Dec 31, 2014 73,669.35